Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MR-LINAC, a New Partner in Radiation Oncology: Current Landscape.
Ocanto A, Torres L, Montijano M, Rincón D, Fernández C, Sevilla B, Gonsalves D, Teja M, Guijarro M, Glaría L, Hernánz R, Zafra-Martin J, Sanmamed N, Kishan A, Alongi F, Moghanaki D, Nagar H, Couñago F. Ocanto A, et al. Among authors: guijarro m. Cancers (Basel). 2024 Jan 8;16(2):270. doi: 10.3390/cancers16020270. Cancers (Basel). 2024. PMID: 38254760 Free PMC article. Review.
Prostate Cancer: Management of Biochemical Recurrence after Surgery.
Moreno-Olmedo E, Suárez-Gironzini V, Fusco JP, Ruiz L, Begara J, Guijarro M, González San Segundo C, Zafra J, López Campos F, Couñago F. Moreno-Olmedo E, et al. Among authors: guijarro m. Arch Esp Urol. 2023 Dec;76(10):733-745. doi: 10.56434/j.arch.esp.urol.20237610.89. Arch Esp Urol. 2023. PMID: 38186066 Free article. Review.
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain.
Gonsalves D, Ocanto A, Meilan E, Gomez A, Dominguez J, Torres L, Pascual CF, Teja M, Linde MM, Guijarro M, Rivas D, Begara J, González JA, Andreescu J, Holgado E, Alcaraz D, López E, Dzhugashvli M, Lopez-Campos F, Alongi F, Couñago F. Gonsalves D, et al. Among authors: guijarro m. Cancers (Basel). 2024 Apr 26;16(9):1685. doi: 10.3390/cancers16091685. Cancers (Basel). 2024. PMID: 38730637 Free PMC article.
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.
Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M, Anto RJ. Haritha NH, et al. Among authors: guijarro mv. Front Oncol. 2023 Dec 15;13:1302413. doi: 10.3389/fonc.2023.1302413. eCollection 2023. Front Oncol. 2023. PMID: 38162481 Free PMC article.
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival.
Guijarro MV, Kellish PC, Dib PE, Paciaroni NG, Nawab A, Andring J, Kulemina L, Borrero NV, Modenutti C, Feely M, Nasri E, Seifert RP, Luo X, Bennett RL, Shabashvili D, Licht JD, McKenna R, Roitberg A, Huigens RW 3rd, Kaye FJ, Zajac-Kaye M. Guijarro MV, et al. JCI Insight. 2023 Apr 25;8(10):e158798. doi: 10.1172/jci.insight.158798. JCI Insight. 2023. PMID: 37097751 Free PMC article.
97 results